MSB 10.4% $1.49 mesoblast limited

CHF - The real phase 3 headlines

  1. 4,196 Posts.
    lightbulb Created with Sketch. 5493
    More protection:
    99.8% confidence amongst all treated patients that there was a 60% reduction of non fatal stroke / Heart attacks.

    Disease modifying:
    99.6% confidence that treated class 2 patients never progressed to being class 3 over a 20 month period.

    Better Outcomes:
    96.3% confidence of a 60% mortality reduction in 206 class 2 patient group treated vs control

    I cannot wait for the partership announcement. Its going to shock a load of people. There will be no burning of shorts.... vaporisation only.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.